Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000080.xml
Download PDF
Sleep Breath 2002; 06(4): 181-188
DOI: 10.1055/s-2002-36529
DOI: 10.1055/s-2002-36529
COMMENTARY
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662
Pulmonary Hypertension, Sleep-Disordered Breathing, and Beta Blockers in Heart Failure Patients
Further Information
Publication History
Publication Date:
13 January 2003 (online)
ABSTRACT
Heart failure patients with pulmonary hypertension have a worse prognosis than heart failure patients with normal pulmonary artery pressures. Heart failure is usually considered the cause of the pulmonary hypertension when the two conditions coincide. However, there is evidence that sleep-disordered breathing may be responsible for the pulmonary hypertension in these patients, and the worsened outcomes in heart failure patients with pulmonary hypertension may be due to sleep-disordered breathing. In addition, sleep-disordered breathing may provide an explanation for the beneficial effect of beta-adrenergic antagonists in heart failure patients.
KEYWORD
Heart failure - sleep-disordered breathing - pulmonary hypertension - beta-adrenergic blockers
REFERENCES
- 1 Abramson S V, Burke J F, Kelly J J. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med . 1992; 116 888-895
- 2 Enriquez-Sarano M, Rossi A, Seward J B, Bailey K R, Tajik A J. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol . 1997; 29 153-158
- 3 Tribouilloy C M, Enriquez-Sarano M, Rossi A, Tajik A J, Seward J B. Determinants of the pulmonary artery pressure rise in left ventricular dysfunction. Cardiologia . 1997; 42 1051-1058
- 4 Capomolla S, Febo O, Guazzotti G. Invasive and non-invasive determinants of pulmonary hypertension in patients with chronic heart failure. J Heart Lung Transplant . 2000; 19 426-438
- 5 Blankfield R P, Tapolyai A A, Zyzanski S J. Left ventricular dysfunction, pulmonary hypertension, obesity and sleep apnea. Sleep Breath . 2001; 5 57-62
- 6 Rich S, Braunwald E, Grossman W. Pulmonary hypertension. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine
5th ed. Philadelphia: WB Saunders Co 1997: 780-806
MissingFormLabel
- 7 Rubin L J. Primary pulmonary hypertension: ACCP consensus statement. Chest . 1993; 104 236-250
- 8 Schroeder J S, Motta J, Guilleminault C. Hemodynamic studies in sleep apnea. In: Guilleminault C, Dement WC, eds. Sleep Apnea Syndromes
New York: Alan R Liss 1978: 177-196
MissingFormLabel
- 9 Shepard J W. Hemodynamics in obstructive sleep apnea. In: Fletcher EC, ed. Abnormalities of Respiration During Sleep
Orlando, FL: Grune & Stratton 1986: 39-63
MissingFormLabel
- 10 Kessler R, Chaouat A, Weitzenblum E. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J . 1996; 9 787-794
- 11 Sanner B M, Doberauer C, Konerman M, Sturm A, Zidek W. Pulmonary hypertension in patients with obstructive sleep apnea. Arch Intern Med . 1997; 157 2483-2487
- 12 Chaouat A, Weitzenblum E, Krieger J, Oswald M, Kessler R. Pulmonary hemodynamics in the obstructive sleep apnea syndrome: results in 220 consecutive patients. Chest . 1996; 109 380-386
- 13 Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S, Jordanoglou J B. Daytime pulmonary hypertension in patients with obstructive sleep apnea. Respiration . 2001; 68 566-572
- 14 Sajkov D, Wang T, Saunders N A, Bune A J, McEvoy R D. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med . 2002; 165 152-158
- 15 McDonnell P J, Toye P A, Hutchins G M. Primary pulmonary hypertension and cirrhosis: are they related?. Am Rev Respir Dis . 1983; 127 437-441
- 16 Hadengue A, Benhayoun M K, Lebrec D, Benhamou J. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology . 1991; 100 520-528
- 17 Kleiger R E, Boxer M, Ingham R E, Harrison D C. Pulmonary hypertension in patients using oral contraceptives: a report of six cases. Chest . 1976; 69 143-147
- 18 Masi A T. Pulmonary hypertension and oral contraceptive usage. Chest . 1976; 69 451-453
- 19 Dawkins K D, Burke C M, Billingham M E, Jamieson S W. Primary pulmonary hypertension and pregnancy. Chest . 1986; 89 383-388
- 20 Rich S, Dantkzer D R, Ayres S M. Primary pulmonary hypertension: a national prospective study. Ann Intern Med . 1987; 107 216-223
- 21 Shaiberger P H, Kennedy T C, Miller F C, Gal J, Petty T L. Pulmonary hypertension associated with long-term inhalation of ``crank'' methamphetamine. Chest . 1993; 104 614-616
- 22 Collins E, Hardwick H, Jeffrey H. Perinatal cocaine intoxication. Med J Aust . 1989; 150 331-332
- 23 Russell L A, Spehlmann J C, Clarke M, Lillington G A. Pulmonary hypertension in female crack users [abstract]. Am Rev Resp Dis . 1992; 145(suppl) A717
- 24 Legoux B, Piette A M, Bouchet P F, Landau J F, Gepner P, Chapman A M. Pulmonary hypertension and HIV infection. Am J Med . 1990; 89 122
- 25 Petitpretz P, Brenot R, Azarian R. Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation . 1994; 89 2722-2727
- 26 Speich R, Jenni M D, Opravil M, Pfab M, Russi E W. Primary pulmonary hypertension in HIV infection. Chest . 1991; 100 1268-1271
- 27 Brenot F, Herve P, Petitpretz P, Parent F, Duroux P, Simonneau G. Primary pulmonary hypertension and fenfluramine use. Br Heart J . 1993; 70 537-541
- 28 Douglas J G, Munro J F, Kitchin A H, Muir A L, Proudfoot A T. Pulmonary hypertension and fenfluramine. BMJ . 1981; 283 881-883
- 29 Gurtner H P. Aminorex and pulmonary hypertension. Cor Vasa . 1985; 27 160-171
- 30 Abenhaim L, Moride Y, Brenot F. Appetite suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med . 1996; 335 609-616
- 31 International Primary Pulmonary Hypertension Study Group. The international primary pulmonary hypertension study (IPPHS). Chest . 1994; 105 37S-41S
- 32 Jahaveri S, Parker T J, Wexler L. Occult sleep-disorder breathing in stable congestive heart failure. Ann Intern Med . 1995; 122 487-492
- 33 Jahaveri S, Parker T J, Liming J D. Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation . 1998; 97 2154-2159
- 34 Chan J, Sanderson J, Chan W. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest . 1997; 111 1488-1493
- 35 Sin D D, Fitzgerald F, Parker J D, Newton G, Floras J S, Bradley T D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med . 1999; 160 1101-1106
- 36 Tremel F, Pepin J L, Veale D. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated for over 2 months. Eur Heart J . 1999; 20 1201-1209
- 37 Lafaso F, Verschueren P, Rande J LD, Harf A, Goldenberg F. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest . 1994; 106 1689-1694
- 38 Solin P, Bergin P, Richardson M, Kaye D M, Walters E H, Naughton M T. Influence of pulmonary wedge pressure on central apnea in heart failure. Circulation . 1999; 99 1574-1579
- 39 Dark D S, Pingleton S K, Kerby G R. Breathing pattern abnormalities and arterial oxygen desaturation during sleep in the congestive heart failure syndrome. Chest . 1987; 91 833-836
- 40 Walsh J T, Andrews R, Starling R, Cowley A J, Johnston I DA. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J . 1995; 73 237-241
- 41 Sin D D, Logan A G, Fitzgerald F S, Liu P P, Bradley T D. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation . 2000; 102 61-66
- 42 Malone S, Liu P P, Holloway R. Obstructive sleep apnea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet . 1991; 338 1480-1484
- 43 Takasaki Y, Orr D, Popkin J, Rutherford R. Effect of nasal continuous positive airway pressure on sleep apnea in congestive heart failure. Am Rev Respir Dis . 1989; 140 1578-1584
- 44 Davies R JO, Harrington K J, Ormerod O JM, Stradling J R. Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis . 1993; 147 630-634
- 45 Hanly P J, Zuberi-Khokar N S. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med . 1996; 153 272-276
- 46 Lanfranchi P A, Braghiroli A, Bosimini E. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation . 1999; 99 1435-1440
- 47 Andreas S, Hagenah G, Möller C, Werner G S, Kreuzer H. Cheyne-Stokes respiration and prognosis in congestive heart failure. Am J Cardiol . 1996; 78 1260-1264
- 48 Barbé F, Mayorales L R, Duran J. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness: a randomized, controlled trial. Ann Intern Med . 2001; 134 1015-1023
- 49 Blankfield R P, Zyzanski S J. Bilateral leg edema, pulmonary hypertension, and obstructive sleep apnea. J Fam Pract . 2002; 51 561-564
- 50 Caruana L, Petrie M C, Davie A P, McMurray J J. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from ``diastolic heart failure'' or from misdiagnosis?. <~>A prospective descriptive study. BMJ . 2000; 321 215-218
- 51 Packer M, Bristow M R, Cohn J N. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med . 1996; 334 1349-1355
- 52 CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet . 1999; 353 9-13
- 53 MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet . 1999; 353 2001-2007
- 54 Packer M, Cohn J N. Consensus recommendations for the management of chronic heart failure. Am J Cardiol . 1999; 83(suppl) 1A-38A
- 55 Bristow M R. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol . 1997; 80 26L-46L
- 56 Kaye D M, Johnston L, Vaddadi G, Brunner-LaRocca H, Jennings G L, Esler M D. Mechanisms of carvedilol action in human congestive heart failure. Hypertension . 2001; 37 1216-1221
- 57 Ziegler M G, Nelesen R, Mills P. Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep . 1997; 20 224-231
- 58 Dimsdale J E, Coy T, Ziegler M G. The effect of sleep apnea on plasma and urinary catecholamines. Sleep . 1995; 18 377-381
- 59 Van de Borne P, Oren R, Abouassaly C, Anderson E, Somers V K. Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol . 1998; 81 432-436
- 60 Minemura H, Akashiba T, Yamamoto H. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med . 1998; 37 1009-1013
- 61 Bratel T, Wennlund A, Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med . 1999; 93 1-7
- 62 Fletcher E C, Miller J, Schaaf J W, Fletcher J G. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep . 1987; 10 35-44
- 63 Kaye D M, Mansfield D, Aggarwal A, Naughton M T, Esler M D. Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation . 2001; 103 2336-2338
- 64 Kaye D M, Jennings G L, Dart A M, Esler M D. Differential effect of acute baroreceptor unloading on cardiac and systemic tone in congestive heart failure. J Am Coll Cardiol . 1998; 31 583-587
- 65 Bradley T D, Logan A G, Floras J S, The CANPAP Investigators. Rationale and design of the Canadian continuous positive airway pressure trial for congestive heart failure patients with central sleep apnea-CANPAP. Can J Cardiol . 2001; 17 677-684
- 66 The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Eng J Med . 1987; 316 1429-1435
- 67 The SOLVD Investigators. Effect of angiotensin-converting enzyme inhibition with enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure: results of the Treatment Trial of the Studies of Left Ventricular Dysfunction (SOLVD): a randomized double blind trial. N Engl J Med . 1991; 325 293-302
- 68 Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity of patients with heart failure. JAMA . 1991; 273 1450-1456